Marianna Piras, PharmD, PhD, is affiliated with the Unit of Pharmacogenetics and Clinical Psychopharmacology at the Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Switzerland. Her publications from 2022 to 2024 focus on the effects of psychotropic medication doses, specifically valproate and risperidone, on weight and metabolic parameters in adult patients with bipolar and psychotic disorders. She has collaborated frequently with Armin von Gunten, Chin B. Eap, Claire Grosu, Franziska Gamma, and Nermine Laaboub.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
